Skin Cancer

Cancer not only wages war on our bodies, but also our relationships with food. Are cancer-fighting diets really the answer?

Clinical trials are a crucial aspect in deciding therapies for patient populations with high-risk melanoma.

While the summer months are the perfect time for outdoor activities with friends and family, it is crucial to protect yourself from skin cancer.

Promising clinical activity and acceptable safety was shown when the PD-1 inhibitor Keytruda (pembrolizumab) was given with the HDAC inhibitor entinostat for patients with melanoma who were refractory to immune checkpoint inhibitors.

There is hot debate over whether full-body skin exams should be done each year to help in early detection of both non-melanoma and melanoma skin cancers.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Opdivo (nivolumab) plus Yervoy (ipilimumab) demonstrated a response in some patients with melanoma brain metastases, according to a recent study presented at ASCO.

A recent clinical trial showed that psychological intervention can ease patients' anxiety and fear of recurrence.

Researchers found that nearly 75 percent of sunscreen products contain less SPF than labeled, and the Environmental Working Group (EWG) is working to have that changed.

Patients with in immunotherapy-naïve and pretreated patients with advanced melanoma saw a 50 percent overall response rate (ORR) when adding a formulation of the Coxsackievirus A21 (CVA21; CAVATAK®) to Yervoy (ipilimumab) – a combination which was well-tolerated.

A plan for remembering your loved one when times get tough.

Non-invasive imaging devices can help dermatologists examine the skin and a lesion without a biopsy, which requires cutting of the skin.

Since being diagnosed with desmoplastic melanoma in 2016, Holly Rowe has teamed up with the Melanoma Research Foundation to spread awareness of skin cancer.

As we approach summer, a melanoma survivor recovers from her fresh wounds and shares her thoughts.

All is NOT fair in love and war

Immunotherapy showed improved survival benefits for stage 3 and 4 melanoma, but it came at a price of greater toxicity, according to a randomized, double-blind phase 3 study that compared 10 mg/kg Yervoy (ipilimumab) or a lower dose of the anti-CTLA-4 anticlonal antibody.

Breast cancer survivor looks back and describes her radiation treatment and shares her tips.

A two-time cancer survivor, breast cancer and melanoma, discusses the empty nest process and cancer.

Cancer survivor discusses interviewing for jobs and returning to employment after surviving breast cancer and melanoma.

What about hope? Don’t kill hope. Breast cancer and melanoma survivor shares what helped at the time of diagnosis and early on in her cancer treatment.

An ongoing trial studying Keytruda (pembrolizumab) with the first-in-class IDO1 inhibitor epacadostat (INCB024360) can mean drastic change for patients with melanoma.

Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma.

Kiran K. Turaga explains that, even with all the advancements and novel treatments in melanoma, surgery is still critical.

Breast cancer and melanoma survivor says you are allowed to feel what you are feeling, whatever that is.

Robert Andtbacka, M.D., C.M., discusses the importance of communication between patients and health care professionals during melanoma surgery.